BIO Asia-Taiwan 2024

24 – 28 July 2024 │ Taipei, Taiwan

Join the Australia Pavilion to unlock business opportunities at BIO Asia-Taiwan 2024

About the event

BIO Asia-Taiwan is one of the premier, annual biotechnology events in Asia. In 2023, more than 120,000 exhibition visitors from 56 countries and 800 exhibitors joined BIO Asia-Taiwan. The event is a highly effective platform for your company to explore business opportunities and connect with key industry players. Participation offers a wide range of activities, including exhibition, conference and business matching and networking events.
 

Austrade Taipei is now inviting key Australian biotech companies to join its bespoke program at BIO Asia-Taiwan from 24 to 28 July 2024 in Taipei, Taiwan.  The highlights of Austrade program consist of the following:

1.    Australia-Taiwan Biotech Collaboration Forum, 24 July
This Forum is a platform to promote Australian biotech capabilities and competitive advantage to an audience of likeminded Taiwanese biotech companies interested in commercial partnerships. The Forum offers value-added experiences for Australian business such as speaking opportunities and a one-on-one business matching program.

In 2023, the Forum attracted 130 executives from 80 major biotech organizations followed on-site by over 120 one-on-one business matching meetings.

2.    Exhibition at Australia Pavilion at BIO Asia-Taiwan, 25-28 July
Share collective space to display your industry capabilities at the Australia Pavilion and to connect with new contacts and engage with existing contacts.

In 2023, the Australia Pavilion at BIO Asia-Taiwan was one of the largest and busiest platforms for Australian companies to showcase Australian clinical trials and biotech capabilities.

Express your interest

Why you should participate

Participation includes:
•    Raise your company profile and showcase your solutions via speaking opportunities to at the Australia-Taiwan Biotech Collaboration Forum
•    Meet potential customers and generating opportunities through one-on-one business matching meetings
•    Advance business connections at an exclusive networking function with major Taiwan
biomedical industry’s contacts
•    Enhance understanding and market intelligence for future partnership and collaboration, commercialisation, and export opportunities in biotech, drug development, research collaboration, and more
•    Receive firsthand feedback on market fit for your products and services from Taiwanese corporates
•    Maximise your company presence, accelerate reputation and brand in the Australian Government’s Australia Pavilion, branded with Australia’s official Nation Brand and the badge of government
•    Gain on-the-ground assistance from Austrade and advice on how to successfully enter and operate in Taiwan market

Important Information

24 – 28 July 2024

Taipei, Taiwan

Who should participate?

The program suits companies with innovative and competitive capabilities operating in (but not limited to):
•    Clinical trials and CRO companies
•    CDMO
•    Advanced therapeutics
•    Precision medicine
•    Medical research organisations

Event Program

Wednesday, 24 July 2024
	13:00 – 18:00	Australia-Taiwan Biotech Collaboration Forum and Individual One-on-One Business Matching Meetings
Thursday, 25 July 2024
	10:00 – 18:00	Exhibition at Australia Pavilion
	18:30 – 20:00	Networking Event hosted by Austrade (by invitation)
Friday, 26 July 2024
	10:00 – 18:00	Exhibition at Australia Pavilion
Saturday, 27 July 2024
	10:00 – 18:00	Exhibition at Australia Pavilion
Sunday, 28 July 2024
	10:00 – 17:00	Exhibition at Australia Pavilion

Your participation cost

A$2,600

Package includes:
•    Exhibition booth fee - shared space under Australia Pavilion
•    Booth design
•    Forum venue fee
•    Event catering
•    Marketing collateral
•    Networking event
•    Event coordination and management
•    Event marketing and promotion
 

Payment

Clients are expected to cover:

• participation fees as outlined in their chosen package
• all travel, accommodation and incidental costs
• freight costs for samples and physical collateral

Austrade requires payment upfront for all international events. The payment term is 7 days from invoice date and your place is not fully secured until the entire fee is paid.

Please refer to the event Terms of event participation | Austrade for further detail. Non-payment by the applied deadline will result in the forfeit of your reserved place on the event.

You may also be eligible to claim some of your marketing and promotion costs associated with this exhibition through the Export Market Development Grant scheme. For more information visit www.austrade.gov.au/grants or call 13 28 78.

Apply before 22 March 2024.

Express your interest

Insights about Taiwan BioTech industry 

•    Taiwan's healthcare system ranked the world's best (Numbeo, 2022)
•    Taiwan’s biomedical industry continues to experience steady growth valued at A$33.7 billion revenue in 2022. The total number of biotech companies in Taiwan (healthcare and digital medicine excluded) increased to 2,350 with 2.6% growth in 2022.
•    Taiwan Government commits to expand the biotechnology industry into a NT$1 trillion (AUD49 billion) value industry through various initiatives, established biomedicine clusters and tweaked policies to achieve this goal.
•    The Taiwan Government set to launch 20 new drugs and 80 medical devices to global markets by 2025. Over ten biotechnology and health-related flagship brands to be fostered globally per the Biomedical Development Plan, driving a strong need for clinical trials and licensing-in of new IP to grow Taiwan’s biomedical sector pipeline.
•    Australia-Taiwan Health and Biotechnology Partnership signed between the Australian Office and the Ministry of Health and Welfare, and the Ministry of Economic Affairs in May 2023 provides a framework for further collaboration in key biotech areas.
•    Taiwan is highly rated in the world competitiveness rankings - the 7th in the world and the 3rd in Asia (World Competitiveness Yearbook, IMD, 2022). Taiwan continues competitiveness through open market & level playing field for all companies, local and international.

Important information

If you are considering this tradeshow, Austrade recommends that you consult ‘Smartraveller’, the Australian Government's travel advisory service, which is available at www.smartraveller.gov.au. Travel advice is updated regularly on this site. Please note that Austrade will only work with clients that maintain appropriate business ethics and demonstrate a commitment to legal obligations including anti-bribery laws, both in Australia and overseas markets. Review further information on anti-bribery at http://www.austrade.gov.au/Exporters/About-exporting/Legal-issues/Bribery-of-foreign-public-officals.

Key Austrade contacts

If you would like to discuss participating in this trade show, please contact:

Austrade Taiwan Health Team
Duli Chang Senior Business Development Manager Austrade Taipei T +886 2 8758 4207 M + 886 935207966 E duli.chang@austrade.gov.au	Sam Huang Business Development Manager Austrade Taipei T:+886 2 8758 4228 M:+886 920 428 333 E sam.huang@austrade.gov.au

BIO Asia-Taiwan 2024 is organised by: 

Visit https://bioasiataiwan.com/ for more information about this tradeshow.